We updated the design of this site on December 18, 2017. Learn more.
ClinicalTrials.gov Menu

Finnish Telestroke Pilot 2007-2009

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01136993
Recruitment Status : Unknown
Verified June 2010 by Helsinki University Central Hospital.
Recruitment status was:  Recruiting
First Posted : June 4, 2010
Last Update Posted : June 4, 2010
Information provided by:

Study Description
Brief Summary:

Objective is to describe two years experience from The Finnish Telestroke piloting between Helsinki University Central Hospital (HUCH), Department of Neurology, The Hub, and five hospitals, the spokes. The participating hospitals are from Rovaniemi (Lapland), Kemi (North-West of Finland), Lappeenranta, Kuusankoski and Kotka from South-East of Finland. All the participating hospitals have a stroke unit and the thrombolysis treatment and the follow up of the patients are carried in the treating hospital. The aim of the pilot is to provide these hospitals expertise in thrombolysis treatment during off-hours through teleconsultations.

The teleconsultations were begun between the participating hospitals 05/2007 after about 1 years preparation period. During the preparation period the staff from participating hospitals were trained with simulation training and lectures held by the local staff and the faculty of the Helsinki University hospital.

Telestroke consultation: During two way interactive audio-visual consultation the thrombolysis decision is based on: 1) the consultant going through a check up list of indications and no contraindications to the treatment together with the treating physician and 2) Clinical assessment of NIHSS by the treating physician under guidance of the consultant through the two way video system besides 3) Evaluation of the head CT scan.

The data registered is based on documents made at HUCH and the follow up data provided by the chief neurologist of the other hospitals. 109 teleconsultations have been documented over 2 years period. A unique feature of the Finnish pilot is the high percentage of consultations leading to thrombolysis treatment. Another special feature is that the consultant does the teleconsultation work besides other on call duties.

Condition or disease

Study Design

Study Type : Observational
Estimated Enrollment : 109 participants
Observational Model: Cohort
Time Perspective: Prospective
Official Title: Finnish Telestroke Pilot 2007-2009
Study Start Date : May 2007
Estimated Primary Completion Date : December 2010
Estimated Study Completion Date : December 2010
Groups and Cohorts

All bi-directional telestroke consultations

Outcome Measures

Primary Outcome Measures :
  1. The percentage of thrombolysis treatments per consultations [ Time Frame: 2 years ]

Secondary Outcome Measures :
  1. Safety (sICH) and Efficacy (mRS at 3 months) compared with on-site thrombolysis [ Time Frame: 2 years ]

Eligibility Criteria

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Ages Eligible for Study:   Child, Adult, Senior
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
All teleconsultations on stroke thrombolysis decision between the Hub (HUCH) and the 5 Spokes during 2 years time period.

Inclusion Criteria:

  • All stroke patients inside 4.5 hours from the symptom onset considered as thrombolysis candidates by the treating physician of the spoke. In suspected basilar artery thrombosis up to 48 h from symptom onset.

Exclusion Criteria:

  • Symptom onset > 4.5 h
Contacts and Locations

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01136993

Contact: Tiina R Sairanen, MD, PhD tiina.sairanen@hus.fi
Contact: Turgut Tatlisumak, MD, PhD turgut.tatlisumak@hus.fi

Department of neurology, HUCH Recruiting
Helsinki, Finland
Principal Investigator: Tiina Sairanen, MD, PhD         
Sponsors and Collaborators
Helsinki University Central Hospital
Kuusankoski Regional Hospital Kuusankoski Finland
Kymenlaakso Central Hospital Kotka Finland
Tampere University Hospital
Central Hospital of Lapland Rovaniemi Finland
South Carelia Central Hospital
Länsi-Pohja Central Hospital Kemi Finland
Principal Investigator: Tiina Sairanen, MD, PhD Department of Neurology, HUCH, Helsinki, Finland
More Information

Responsible Party: Dr. Tiina Sairanen, Department of Neurology, HUCH, Helsinki, Finland
ClinicalTrials.gov Identifier: NCT01136993     History of Changes
Other Study ID Numbers: M1010NL0002
First Posted: June 4, 2010    Key Record Dates
Last Update Posted: June 4, 2010
Last Verified: June 2010

Keywords provided by Helsinki University Central Hospital: